Home / Leuprorelin / Norway
NO ATC L02AE02 · updated 2 Nov 2026
Leuprorelin shortage in Norway
Is there a Leuprorelin shortage in Norway?
Yes. As of 2 Nov 2026, 1 Leuprorelin product is reported short in Norway, the first since 29 Oct 2026. The company estimate for the return is 15 Jan 2027. Main reason: manufacturing problem.
Also short in Canada, France, Italy, Austria. All countries.
Affected products in Norway
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| NO | Eligard 22,5 mg pulver og væske til injeksjonsvæske, oppløsning i ferdigfylt sprøyte, 1 sett ferdigfylt sprøyte | Recordati Industria Chimica e Farmaceutica S.p.A. | 29 Oct 2026 | 15 Jan 2027 | Manufacturing problem Produksjonsproblemer |
Source
DMP (Norwegian Medical Products Agency). Official list. Ongoing and announced shortages reported by companies; one row per pack (varenummer).